1. Home
  2. MAIN vs BLCO Comparison

MAIN vs BLCO Comparison

Compare MAIN & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Main Street Capital Corporation

MAIN

Main Street Capital Corporation

HOLD

Current Price

$64.09

Market Cap

5.4B

Sector

Finance

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.24

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAIN
BLCO
Founded
2007
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance/Investors Services
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.0B
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
MAIN
BLCO
Price
$64.09
$17.24
Analyst Decision
Hold
Hold
Analyst Count
7
14
Target Price
$61.57
$17.31
AVG Volume (30 Days)
598.4K
332.5K
Earning Date
02-26-2026
02-18-2026
Dividend Yield
6.75%
N/A
EPS Growth
9.38
N/A
EPS
6.03
N/A
Revenue
$561,290,000.00
$4,976,000,000.00
Revenue This Year
$5.53
$8.06
Revenue Next Year
$2.24
$5.79
P/E Ratio
$10.61
N/A
Revenue Growth
5.92
6.23
52 Week Low
$47.00
$10.45
52 Week High
$67.77
$18.14

Technical Indicators

Market Signals
Indicator
MAIN
BLCO
Relative Strength Index (RSI) 64.23 56.07
Support Level $60.40 $17.18
Resistance Level $64.59 $17.86
Average True Range (ATR) 1.37 0.42
MACD 0.24 -0.02
Stochastic Oscillator 89.88 64.63

Price Performance

Historical Comparison
MAIN
BLCO

About MAIN Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: